https://www.thebodypro.com/tag/news

News

The Latest

Vaccination being filled

Investigational PrEP Injection, Dosed Every Other Month, Beats Daily PrEP in Phase 3 Study

New data presented at AIDS 2020 show the long-acting injectable drug cabotegravir proved superior to daily oral TDF/FTC for MSM and transgender women.

By Kenyon Farrow
woman's feet on scale

Body Mass Index Among People With HIV Is Rising Much Faster Than the General Population

People living with HIV in the U.S. are experiencing increases in body mass index at a rate three times greater than that of the general U.S. population, according to new research presented at AIDS 2020.

By Myles Helfand
staying in touch

HIV Care and Coronavirus (COVID-19): The Latest Info and Guidance

Multiple U.S. health agencies have released HIV-specific information, and research on HIV and the novel coronavirus is trickling in. Here's what health care providers need to know.

By Myles Helfand and Sony Salzman
slacklining

This Week in HIV Research: So Many Relative Risks

July 1, 2020: Quantifying bone fracture risks; real-world lipid effects of switching to TAF; pulmonary function impairment in MSM; immunomodulatory drugs and viral load blips.

By Barbara Jungwirth and Myles Helfand
doctor stop

Does Taking HIV Meds Reduce the Odds of COVID-19? Experts Say, ‘Not So Fast’

A newly published study linking HIV medication to reduction in COVID-19 risk has many problems, experts warn.

By Kenyon Farrow
bridging the chasm

This Week in HIV Research: Closing Our Care Chasms

June 25, 2020: 25 years of HOPS; successes of San Francisco’s test-and-treat program; missed opportunities to test people who inject drugs; how patient-provider trust can curb prescribing cascades.

By Barbara Jungwirth and Myles Helfand
white man black man

This Week in HIV Research: Existing Solutions Won't Close the Race Gap

June 18, 2020: Existing evidence-based interventions aren't enough to close HIV's racial gap; transgender patient outcomes in the HIV care continuum; meeting long-term needs of formerly incarcerated people; acute respiratory illness severity and HIV status.

By Barbara Jungwirth and Myles Helfand
Truvada

New Study Shows Effectiveness of On-Demand PrEP

Kaiser Permanente’s 2-1-1 pre-exposure prophylaxis (PrEP) program shows event-driven dosing works.

By Larry Buhl
raising the bar

This Week in HIV Research: Setting a New Bar

June 11, 2020: Diagnosis rates within a year of infection; rates of intentional non-daily PrEP use; neurological development in children of birth parents with HIV; point-of-care urine test to assess tenofovir levels.

By Barbara Jungwirth and Myles Helfand
Newton's Cradle

When People Stop Newer HIV Meds, Time to Viral Rebound Not Better Than With Older Antiretroviral Therapy, NIH Study Finds

Researchers are trying to understand treatment interruptions as part of work to develop a future HIV cure and therapies that will not involve medications.

By Martha Kempner